Publications by authors named "J Snobre"

Claim this Profile
H
High-dose amikacin in the first week of all-oral rifampicin-resistant TB treatment is safe: a single-arm trial.
J Snobre, J Gasana, T Decroo, Y Mucyo, B K M Jacobs

IJTLD Open· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to Schön et al., "Quality control and considering systematic MIC shifts are key when evaluating the role of () frameshifts in bedaquiline resistance".
J Snobre, C J Meehan, W Mulders, L Rigouts, R Buyl

Antimicrob Agents Chemother· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frameshift mutations in the gene can have a bedaquiline-susceptible phenotype by retaining a protein structure and function similar to wild-type .
J Snobre, C J Meehan, W Mulders, L Rigouts, R Buyl

Antimicrob Agents Chemother· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single nucleotide variation catalog from clinical isolates mapped on tertiary and quaternary structures of ESX-1-related proteins reveals critical regions as putative Mtb therapeutic targets.
Oren Tzfadia, Abril Gijsbers, Alexandra Vujkovic, Jihad Snobre, Roger Vargas

Microbiol Spectr· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of high-dose amikacin in the first week of all-oral rifampicin-resistant tuberculosis treatment for the prevention of acquired resistance (STAKE): protocol for a single-arm clinical trial.
Jihad Snobre, Joel Gasana, Jean Claude Semuto Ngabonziza, Isabel Cuella-Martin, Leen Rigouts

BMJ Open· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis